APO RESEARCH · REPORT
Budesonide
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.
Product & engineering
Understand the product.
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.
Selected research
Market Analysis & Forecast
Global Budesonide Market Analysis and Forecast 2026-2032
Market perspective
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.
North America is the largest market with about 36% revenue market share. Followed by Asia-Pacific and Europe, accounting for about 60% revenue market share.
The key players are AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod etc. AstraZeneca is the largest manufacturer with about 56% revenue market share.
Read the full market overview
This report presents an overview of global market for Budesonide, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Budesonide, also provides the sales of main regions and countries. Of the upcoming market potential for Budesonide, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Budesonide sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Budesonide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Budesonide sales, projected growth trends, production technology, application and end-user industry.
Budesonide Segment by Company
AstraZeneca
Teva
Mylan
Sandoz
Cosmo Pharmaceuticals
Salix
Chiesi Farmaceutici
Orion Corporation
Cipla
Synmosa Biopharma
Lunan Better Pharma
Shanghai Sine Promod
Budesonide Segment by Type
Injectable Suspension
Aerosols
Inhalation Powder
Tablet and Capsule
Budesonide Segment by Application
Respiratory Disease Treatment
Nose Disease Treatment
Inflammatory Bowel Disease Treatment
Others
Budesonide Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Budesonide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Budesonide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Budesonide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Budesonide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Budesonide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Budesonide sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injectable Suspension
- Aerosols
- Inhalation Powder
- Tablet and Capsule
Applications
- Respiratory Disease Treatment
- Nose Disease Treatment
- Inflammatory Bowel Disease Treatment
- Others
Companies covered
- AstraZeneca
- Teva
- Mylan
- Sandoz
- Cosmo Pharmaceuticals
- Salix
- Chiesi Farmaceutici
- Orion Corporation
- Cipla
- Synmosa Biopharma
- Lunan Better Pharma
- Shanghai Sine Promod
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Budesonide Market by Type
- 1.2.1 Global Budesonide Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Injectable Suspension
- 1.2.3 Aerosols
- 1.2.4 Inhalation Powder
- 1.2.5 Tablet and Capsule
- 1.3 Budesonide Market by Application
- 1.3.1 Global Budesonide Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Respiratory Disease Treatment
- 1.3.3 Nose Disease Treatment
- 1.3.4 Inflammatory Bowel Disease Treatment
- 1.3.5 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Budesonide Market Dynamics
- 2.1 Budesonide Industry Trends
- 2.2 Budesonide Industry Drivers
- 2.3 Budesonide Industry Opportunities and Challenges
- 2.4 Budesonide Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Budesonide Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Budesonide Revenue by Region
- 3.2.1 Global Budesonide Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Budesonide Revenue by Region (2021-2026)
- 3.2.3 Global Budesonide Revenue by Region (2027-2032)
- 3.2.4 Global Budesonide Revenue Market Share by Region (2021-2032)
- 3.3 Global Budesonide Sales Estimates and Forecasts 2021-2032
- 3.4 Global Budesonide Sales by Region
- 3.4.1 Global Budesonide Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Budesonide Sales by Region (2021-2026)
- 3.4.3 Global Budesonide Sales by Region (2027-2032)
- 3.4.4 Global Budesonide Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Budesonide Revenue by Manufacturers
- 4.1.1 Global Budesonide Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Budesonide Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Budesonide Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Budesonide Sales by Manufacturers
- 4.2.1 Global Budesonide Sales by Manufacturers (2021-2026)
- 4.2.2 Global Budesonide Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Budesonide Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Budesonide Sales Price by Manufacturers (2021-2026)
- 4.4 Global Budesonide Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Budesonide Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Budesonide Manufacturers, Product Type & Application
- 4.7 Global Budesonide Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Budesonide Market CR5 and HHI
- 4.8.2 2025 Budesonide Tier 1, Tier 2, and Tier 3
5 Budesonide Market by Type
- 5.1 Global Budesonide Revenue by Type
- 5.1.1 Global Budesonide Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Budesonide Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Budesonide Revenue Market Share by Type (2021-2032)
- 5.2 Global Budesonide Sales by Type
- 5.2.1 Global Budesonide Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Budesonide Sales by Type (2021-2032) & (M Units)
- 5.2.3 Global Budesonide Sales Market Share by Type (2021-2032)
- 5.3 Global Budesonide Price by Type
6 Budesonide Market by Application
- 6.1 Global Budesonide Revenue by Application
- 6.1.1 Global Budesonide Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Budesonide Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Budesonide Revenue Market Share by Application (2021-2032)
- 6.2 Global Budesonide Sales by Application
- 6.2.1 Global Budesonide Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Budesonide Sales by Application (2021-2032) & (M Units)
- 6.2.3 Global Budesonide Sales Market Share by Application (2021-2032)
- 6.3 Global Budesonide Price by Application
7 Company Profiles
- 7.1 AstraZeneca
- 7.1.1 AstraZeneca Company Information
- 7.1.2 AstraZeneca Business Overview
- 7.1.3 AstraZeneca Budesonide Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 AstraZeneca Budesonide Product Portfolio
- 7.1.5 AstraZeneca Recent Developments
- 7.2 Teva
- 7.2.1 Teva Company Information
- 7.2.2 Teva Business Overview
- 7.2.3 Teva Budesonide Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Teva Budesonide Product Portfolio
- 7.2.5 Teva Recent Developments
- 7.3 Mylan
- 7.3.1 Mylan Company Information
- 7.3.2 Mylan Business Overview
- 7.3.3 Mylan Budesonide Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Mylan Budesonide Product Portfolio
- 7.3.5 Mylan Recent Developments
- 7.4 Sandoz
- 7.4.1 Sandoz Company Information
- 7.4.2 Sandoz Business Overview
- 7.4.3 Sandoz Budesonide Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Sandoz Budesonide Product Portfolio
- 7.4.5 Sandoz Recent Developments
- 7.5 Cosmo Pharmaceuticals
- 7.5.1 Cosmo Pharmaceuticals Company Information
- 7.5.2 Cosmo Pharmaceuticals Business Overview
- 7.5.3 Cosmo Pharmaceuticals Budesonide Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Cosmo Pharmaceuticals Budesonide Product Portfolio
- 7.5.5 Cosmo Pharmaceuticals Recent Developments
- 7.6 Salix
- 7.6.1 Salix Company Information
- 7.6.2 Salix Business Overview
- 7.6.3 Salix Budesonide Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Salix Budesonide Product Portfolio
- 7.6.5 Salix Recent Developments
- 7.7 Chiesi Farmaceutici
- 7.7.1 Chiesi Farmaceutici Company Information
- 7.7.2 Chiesi Farmaceutici Business Overview
- 7.7.3 Chiesi Farmaceutici Budesonide Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Chiesi Farmaceutici Budesonide Product Portfolio
- 7.7.5 Chiesi Farmaceutici Recent Developments
- 7.8 Orion Corporation
- 7.8.1 Orion Corporation Company Information
- 7.8.2 Orion Corporation Business Overview
- 7.8.3 Orion Corporation Budesonide Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Orion Corporation Budesonide Product Portfolio
- 7.8.5 Orion Corporation Recent Developments
- 7.9 Cipla
- 7.9.1 Cipla Company Information
- 7.9.2 Cipla Business Overview
- 7.9.3 Cipla Budesonide Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Cipla Budesonide Product Portfolio
- 7.9.5 Cipla Recent Developments
- 7.10 Synmosa Biopharma
- 7.10.1 Synmosa Biopharma Company Information
- 7.10.2 Synmosa Biopharma Business Overview
- 7.10.3 Synmosa Biopharma Budesonide Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Synmosa Biopharma Budesonide Product Portfolio
- 7.10.5 Synmosa Biopharma Recent Developments
- 7.11 Lunan Better Pharma
- 7.11.1 Lunan Better Pharma Company Information
- 7.11.2 Lunan Better Pharma Business Overview
- 7.11.3 Lunan Better Pharma Budesonide Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 Lunan Better Pharma Budesonide Product Portfolio
- 7.11.5 Lunan Better Pharma Recent Developments
- 7.12 Shanghai Sine Promod
- 7.12.1 Shanghai Sine Promod Company Information
- 7.12.2 Shanghai Sine Promod Business Overview
- 7.12.3 Shanghai Sine Promod Budesonide Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 Shanghai Sine Promod Budesonide Product Portfolio
- 7.12.5 Shanghai Sine Promod Recent Developments
8 North America
- 8.1 North America Budesonide Market Size by Type
- 8.1.1 North America Budesonide Revenue by Type (2021-2032)
- 8.1.2 North America Budesonide Sales by Type (2021-2032)
- 8.1.3 North America Budesonide Price by Type (2021-2032)
- 8.2 North America Budesonide Market Size by Application
- 8.2.1 North America Budesonide Revenue by Application (2021-2032)
- 8.2.2 North America Budesonide Sales by Application (2021-2032)
- 8.2.3 North America Budesonide Price by Application (2021-2032)
- 8.3 North America Budesonide Market Size by Country
- 8.3.1 North America Budesonide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Budesonide Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Budesonide Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Budesonide Market Size by Type
- 9.1.1 Europe Budesonide Revenue by Type (2021-2032)
- 9.1.2 Europe Budesonide Sales by Type (2021-2032)
- 9.1.3 Europe Budesonide Price by Type (2021-2032)
- 9.2 Europe Budesonide Market Size by Application
- 9.2.1 Europe Budesonide Revenue by Application (2021-2032)
- 9.2.2 Europe Budesonide Sales by Application (2021-2032)
- 9.2.3 Europe Budesonide Price by Application (2021-2032)
- 9.3 Europe Budesonide Market Size by Country
- 9.3.1 Europe Budesonide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Budesonide Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Budesonide Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Budesonide Market Size by Type
- 10.1.1 China Budesonide Revenue by Type (2021-2032)
- 10.1.2 China Budesonide Sales by Type (2021-2032)
- 10.1.3 China Budesonide Price by Type (2021-2032)
- 10.2 China Budesonide Market Size by Application
- 10.2.1 China Budesonide Revenue by Application (2021-2032)
- 10.2.2 China Budesonide Sales by Application (2021-2032)
- 10.2.3 China Budesonide Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Budesonide Market Size by Type
- 11.1.1 Asia Budesonide Revenue by Type (2021-2032)
- 11.1.2 Asia Budesonide Sales by Type (2021-2032)
- 11.1.3 Asia Budesonide Price by Type (2021-2032)
- 11.2 Asia Budesonide Market Size by Application
- 11.2.1 Asia Budesonide Revenue by Application (2021-2032)
- 11.2.2 Asia Budesonide Sales by Application (2021-2032)
- 11.2.3 Asia Budesonide Price by Application (2021-2032)
- 11.3 Asia Budesonide Market Size by Country
- 11.3.1 Asia Budesonide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Budesonide Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Budesonide Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Budesonide Market Size by Type
- 12.1.1 SAMEA Budesonide Revenue by Type (2021-2032)
- 12.1.2 SAMEA Budesonide Sales by Type (2021-2032)
- 12.1.3 SAMEA Budesonide Price by Type (2021-2032)
- 12.2 SAMEA Budesonide Market Size by Application
- 12.2.1 SAMEA Budesonide Revenue by Application (2021-2032)
- 12.2.2 SAMEA Budesonide Sales by Application (2021-2032)
- 12.2.3 SAMEA Budesonide Price by Application (2021-2032)
- 12.3 SAMEA Budesonide Market Size by Country
- 12.3.1 SAMEA Budesonide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Budesonide Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Budesonide Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Budesonide Value Chain Analysis
- 13.1.1 Budesonide Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Budesonide Production Mode & Process
- 13.2 Budesonide Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Budesonide Distributors
- 13.2.3 Budesonide Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst